CompletedNCT02884544
This study is completed in the United States. It is testing delayed and Extended Release Formulation of Dextroamphetamine Sulfate for ADHD.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Condition
- ADHD
CompletedNCT06273774
This study is completed in the United States. It is testing elpipodect for Bipolarity.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Bipolarity
CompletedNCT05406440
This study is completed in the United States. It is testing elpipodect for schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Schizophrenia
CompletedNCT02006628
This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom, Poland, Romania
- Sponsor
- Jazz Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT00463580
This study is completed in the United States. It is testing infliximab for depression.
DepressionOtherFrom 25 Years to 60 Years
- Countries
- United States
- Sponsor
- Emory University
- Condition
- Depression
CompletedNCT05328297
This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
Bipolarity, DepressionOtherFrom 18 Years to 64 Years
- Countries
- United States, Canada, Poland, ...
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Condition
- Bipolarity, Depression
CompletedNCT04113551
This study is completed in the United States. It is testing label Compliance for ADHD.
ADHDOther
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- ADHD
TerminatedNCT01307800
This study has public registry information in the United States, in Mexico, in Russian Federation, .... It is testing LY2140023 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States, Mexico, Russian Federation, ...
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT01052103
This study is completed in the United States, in Israel, in Italy, .... It is testing LY2140023 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States, Israel, Italy, ...
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT05953740
This study is completed in the United States. It is testing MK-5720 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Schizophrenia
CompletedNCT01174355
This study is completed in Israel. It is testing ND0801 for ADHD.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- Israel
- Sponsor
- NeuroDerm Ltd.
- Condition
- ADHD
Active Not RecruitingNCT06792136
This study is active but not recruiting in Japan. It is testing ONO-1110 for depression.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Japan
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Condition
- Depression
